Adelaide biotech company Reproductive Health Science Ltd to launch latest product to global market
Aug 17, 2016 - latest news
Adelaide, August 2016: Publicly listed Adelaide biotech company Reproductive Health Science Ltd (ASX:RHS) is launching its second product, DOPlify™ onto the global market.
DOPlify™ was introduced at the recent European Society of Human Reproduction and Embryology Conference (ESHRE) held in Helsinki in July 2016. Performance data for DOPlify™ using Next Generation Sequencing (NGS) was presented at the conference by RHS’ Chief Scientific Officer, Dr Melinda Jasper. Managing Director, Dr Michelle Fraser said “since the conference there has been significant interest in the product and we are excited to be launching DOPlify™ locally”.
Click on image below to view release